<i>TP53</i> Targeted Deep Sequencing of Cell-Free DNA in Esophageal Squamous Cell Carcinoma Using Low-Quality Serum: Concordance with Tumor Mutation
Circulating cell-free DNA (cfDNA) is emerging as a potential tumor biomarker. CfDNA-based biomarkers may be applicable in tumors without an available non-invasive screening method among at-risk populations. Esophageal squamous cell carcinoma (ESCC) and residents of the Asian cancer belt are examples...
Main Authors: | Dariush Nasrollahzadeh, Gholamreza Roshandel, Tiffany Myriam Delhomme, Patrice Hodonou Avogbe, Matthieu Foll, Farrokh Saidi, Hossein Poustchi, Masoud Sotoudeh, Reza Malekzadeh, Paul Brennan, James Mckay, Pierre Hainaut, Behnoush Abedi-Ardekani |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-05-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/22/11/5627 |
Similar Items
-
Longitudinal Study of Circulating Biomarkers in Patients with Resectable Pancreatic Ductal Adenocarcinoma
by: Pablo J. Dopico, et al.
Published: (2022-03-01) -
Circulating cell-free DNA and circulating tumor cells, the “liquid biopsies” in ovarian cancer
by: Xianliang Cheng, et al.
Published: (2017-11-01) -
Liquid Biopsies in Solid Cancers: Implementation in a Nordic Healthcare System
by: Oddmund Nordgård, et al.
Published: (2021-04-01) -
Molecular Profiling of Circulating Tumour Cells and Circulating Tumour DNA: Complementary Insights from a Single Blood Sample Utilising the Parsortix<sup>®</sup> System
by: Gabrielle Wishart, et al.
Published: (2024-01-01) -
Clinical Applications of Liquid Biopsy in Prostate Cancer: From Screening to Predictive Biomarker
by: Filip Ionescu, et al.
Published: (2022-03-01)